(134 days)
No
The description focuses on the mechanical components and materials of a bone fracture fixation system. There is no mention of software, algorithms, or data processing that would indicate the use of AI/ML.
No.
This device is an internal fixation system used for long bone fracture fixation, non-unions, and malunions, which are surgical interventions rather than therapeutic treatments that address disease or provide relief from symptoms.
No
The device, AxSOS 3 Ti, is described as an internal fixation system for long bone fracture fixation (e.g., plates, screws, cable plugs). Its intended use is to mechanically stabilize fractures, not to diagnose medical conditions or diseases.
No
The device description explicitly states that the system includes physical components such as plates, screws, and a cable plug, all manufactured from titanium alloy. This indicates it is a hardware medical device, not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for "long bone fracture fixation," addressing various types of fractures, non-unions, malunions, osteotomies, and periprosthetic fractures. This is a surgical intervention for treating physical injuries.
- Device Description: The device is a system of plates, screws, and a cable plug designed for internal fixation of bones. These are implantable components used to mechanically stabilize bone fragments.
- Lack of IVD Characteristics: An IVD is a medical device used to perform tests on samples taken from the human body (like blood, urine, tissue) to provide information about a person's health. The provided description does not mention any testing of biological samples or providing diagnostic information.
The AxSOS 3 Ti system is clearly a surgical implant used for orthopedic procedures, not for in vitro diagnostic testing.
N/A
Intended Use / Indications for Use
AxSOS 3 Ti is intended for long bone fracture fixation
Indications include:
- Diaphyseal, metaphyseal, epiphyseal, extra- and intra-articular fractures
- Non-unions and malunions
- Normal and osteopenic bone
- Osteotomies
- Periprosthetic fractures of the femur and proximal tibia.
The AxSOS 3 Ti Waisted Compression Plates are also indicated for fracture fixation of:
- Periprosthetic fractures
- Diaphyseal and metaphyseal areas of long bones in pediatric patients
The 4mm Waisted Compression Plate indications also include fixation of the scapula and the pelvis.
Product codes (comma separated list FDA assigned to the subject device)
HRS, HWC
Device Description
This traditional 510(k) submission is intended to update the labeling of the AxSOS 3 Ti system to include MR compatibility and to introduce an additional component, the AxSOS 3 Ti 5.0mm Cable Plug. The AxSOS 3 Ti system was previously cleared in K153379 and K162439.
The AxSOS 3 Ti system (also referred to as the AxSOS 3 Ti Locking Plate system) is a system used for internal fixation applications. The system includes anatomically contoured monoaxial locking plates, as well as screws and blind screws (limited to waisted compression plates) . The plates have been designed with holes that can accommodate either locking or non-locking screws, and also include holes for suture and Kirschner wires (K-wires). The screws come in 3 types (locking, cortical, and cancellous) and are available in several different diameters. All implantable components are available sterile and non-sterile and are manufactured from titanium alloy (Ti6Al4V-ELI) per ASTM F136.
The AxSOS 3 Ti 5.0mm Cable Plug is categorized as permanent, direct bone/tissue patient contacting implant with contact duration >30 days. It is manufactured from titanium alloy (ASTM F136, Ti6Al4V-ELI) and is Type II anodized. It is designed to be used in combination with the 5.0mm AxSOS 3 Ti system. It is an aid for internal fixation component used in conjunction with the AxSOS 3 Ti 5.0mm distal lateral femur, broad compression and narrow compression plates. The Cable Plug is threaded or clicked into a 5.0mm universal locking hole of the AxSOS 3 Ti plates and provides a positioning point for a cerclage cable.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
long bone, femur, proximal tibia, scapula, pelvis
Indicated Patient Age Range
pediatric patients
Intended User / Care Setting
Prescription Use (Part 21 CFR 801 Subpart D)
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Testing
Testing was performed to ASTM F543-13 – Pull Out Test and ASTM STP 731-Dynamic Compression Test for the Cable Plug component.
Testing was performed to determine the compatibility of the system in a MR environment. These tests included an assessment of:
- Magnetically Induced Displacement Force per ASTM F2052
- Magnetically Induced Torque per ASTM F2213
- Heating by RF Fields per ASTM F2182
- Image Artifacts per ASTM F2119
Testing demonstrated that the subject device is substantially equivalent to the marketed predicate device.
Animal testing was not required for this submission.
Clinical Testing
Clinical testing was not required for this submission.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
AxSOS 3 Ti (K153379 & K162439), Dall-Miles Homogenous Vitallium Cable (K961283)
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Fixos Screw System (K133451), Asnis III Cannulated Screw System (K000080)
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3030 Single/multiple component metallic bone fixation appliances and accessories.
(a)
Identification. Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image shows the logos of the Department of Health & Human Services and the U.S. Food & Drug Administration. The Department of Health & Human Services logo is on the left, and the U.S. Food & Drug Administration logo is on the right. The FDA logo is blue and white and includes the words "FDA U.S. FOOD & DRUG ADMINISTRATION".
December 15, 2017
Stryker GmbH Kemine Hale Sr. Regulatory Affairs Specialist Bohnackerweg 1 Selzach, 2545 Switzerland
Re: K172350
Trade/Device Name: AxSOS 3 Ti Regulation Number: 21 CFR 888.3030 Regulation Name: Single/Multiple Component Metallic Bone Fixation Appliances And Accessories Regulatory Class: Class II Product Code: HRS, HWC Dated: November 10, 2017 Received: November 13, 2017
Dear Kemine Hale:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820);
1
and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Mark N. Melkerson -S
Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known)
Device Name AxSOS 3 Ti
Indications for Use (Describe)
AxSOS 3 Ti is intended for long bone fracture fixation
Indications include:
-
- Diaphyseal, metaphyseal, epiphyseal, extra- and intra-articular fractures
-
- Non-unions and malunions
-
- Normal and osteopenic bone
-
- Osteotomies
-
- Periprosthetic fractures of the femur and proximal tibia.
The AxSOS 3 Ti Waisted Compression Plates are also indicated for fracture fixation of:
-
- Periprosthetic fractures
-
- Diaphyseal and metaphyseal areas of long bones in pediatric patients
The 4mm Waisted Compression Plate indications also include fixation of the scapula and the pelvis
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Druq Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.
3
510(k) Summary
| Proprietary Name: | AxSOS 3 Ti |
|---|---|
| Common Name: | Bone Plates |
| Bone Screws | |
| Regulation Number & | |
| Regulation Description: | 21 CFR 888.3030: Single/multiple component |
| metallic bone fixation appliances and accessories. | |
| 21 CFR 888.3040: Smooth or threaded metallic bone | |
| fixation fastener | |
| Product Code: | HRS (Plate, Fixation, bone) |
| HWC (Screw, Fixation, Bone/Washer) | |
| Device Class: | Class II |
| Sponsor: | Stryker GmbH |
| Bohnackerweg 1 | |
| 2545 Selzach / Switzerland | |
| Contact Person: | Kemine Hale |
| Sr. Regulatory Affairs Specialist | |
| Bohnackerweg 1 | |
| 2545 Selzach, Switzerland | |
| kemine.hale@stryker.com | |
| Phone: +41 32 641 6935 | |
| Date Prepared: | December 14, 2017 |
| Primary Predicate: | AxSOS 3 Ti (K153379 & K162439) |
| Dall-Miles Homogenous Vitallium Cable (K961283) | |
| Reference Devices: | Fixos Screw System (K133451) |
| Asnis III Cannulated Screw System (K000080) |
510(k) Summary
4
Description
This traditional 510(k) submission is intended to update the labeling of the AxSOS 3 Ti system to include MR compatibility and to introduce an additional component, the AxSOS 3 Ti 5.0mm Cable Plug. The AxSOS 3 Ti system was previously cleared in K153379 and K162439.
The AxSOS 3 Ti system (also referred to as the AxSOS 3 Ti Locking Plate system) is a system used for internal fixation applications. The system includes anatomically contoured monoaxial locking plates, as well as screws and blind screws (limited to waisted compression plates) . The plates have been designed with holes that can accommodate either locking or non-locking screws, and also include holes for suture and Kirschner wires (K-wires). The screws come in 3 types (locking, cortical, and cancellous) and are available in several different diameters. All implantable components are available sterile and non-sterile and are manufactured from titanium alloy (Ti6Al4V-ELI) per ASTM F136.
The AxSOS 3 Ti 5.0mm Cable Plug is categorized as permanent, direct bone/tissue patient contacting implant with contact duration >30 days. It is manufactured from titanium alloy (ASTM F136, Ti6Al4V-ELI) and is Type II anodized. It is designed to be used in combination with the 5.0mm AxSOS 3 Ti system. It is an aid for internal fixation component used in conjunction with the AxSOS 3 Ti 5.0mm distal lateral femur, broad compression and narrow compression plates. The Cable Plug is threaded or clicked into a 5.0mm universal locking hole of the AxSOS 3 Ti plates and provides a positioning point for a cerclage cable.
Indications for Use
AxSOS 3 Ti is intended for long bone fracture fixation.
Indications include:
- Diaphyseal, metaphyseal, epiphyseal, extra- and intra-articular fractures ●
- . Non-unions and malunions
- Normal and osteopenic bone ●
- Osteotomies
- Periprosthetic fractures of the femur and proximal tibia.
5
The AxSOS 3 Ti Waisted Compression Plates are also indicated for fracture fixation of:
- Periprosthetic fractures ●
- o Diaphyseal and metaphyseal areas of long bones in pediatric patients
The 4mm Waisted Compression Plate indications also include fixation of the scapula and the pelvis.
Summary of Technologies
A comparison of the systems demonstrated the subject AxSOS 3 Ti system is substantially equivalent to the previously cleared AxSOS 3 Ti system (K162439) and the Dall-Miles Homogenous Vitallium Cable (K961283) with regards to intended use, material, design and operational principles.
Non-Clinical Testing
Testing was performed to ASTM F543-13 – Pull Out Test and ASTM STP 731-Dynamic Compression Test for the Cable Plug component.
Testing was performed to determine the compatibility of the system in a MR environment. These tests included an assessment of:
- o Magnetically Induced Displacement Force per ASTM F2052
- Magnetically Induced Torque per ASTM F2213 ●
- Heating by RF Fields per ASTM F2182
- Image Artifacts per ASTM F2119
Testing demonstrated that the subject device is substantially equivalent to the marketed predicate device.
Animal testing was not required for this submission.
Clinical Testing
Clinical testing was not required for this submission.
Conclusion
510(k) Summary
6
The AxSOS 3 Ti system described in this submission is identical to the previously cleared predicate, K153379, K162439 and K961283, with the exception of the additional component. Non-clinical testing has been used to support substantial equivalence. The testing demonstrated that the subject system performs as intended and at least as well as the predicate. Based on these attributes the subject AxSOS 3 Ti is substantially equivalent to the Stryker GmbH AxSOS 3 Ti system and the Dall-Miles Homogenous Vitallium Cable.